Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1

被引：0
|
作者：
François Bertucci
Anthony Gonçalves
机构：
[1] Institut Paoli-Calmettes,Department of Medical Oncology
[2] Department of Molecular Oncology,Faculty of Medicine
[3] Centre de Recherche en Cancérologie de Marseille (CRCM),undefined
[4] CNRS U7258,undefined
[5] INSERM U1068,undefined
[6] Aix-Marseille University,undefined
来源：
Current Oncology Reports | 2017年 / 19卷
关键词：
Breast cancer; Expression; Immune response; Monoclonal antibodies; PD-1; PD-L1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [22] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
    Chretien, Sebastian
    Zerdes, Ioannis
    Bergh, Jonas
    Matikas, Alexios
    Foukakis, Theodoros
    CANCERS, 2019, 11 (05)
  • [23] The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
    Setordzi, Patience
    Chang, Xing
    Liu, Zi
    Wu, Yingliang
    Zuo, Daiying
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 895
  • [24] Evolving perspectives regarding the role of the PD-1/PD-L1 pathway in gastric cancer immunotherapy
    Yu, Xianzhe
    Zhai, Xiaoqian
    Wu, Juan
    Feng, Qingbo
    Hu, Chenggong
    Zhu, Lingling
    Zhou, Qinghua
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (01):
  • [25] The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy
    Cai, Jiajing
    Wang, Dongsheng
    Zhang, Guoyuan
    Guo, Xiaolan
    ONCOTARGETS AND THERAPY, 2019, 12 : 8437 - 8445
  • [26] PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
    Ren, Xiaohui
    Wang, Lijuan
    Liu, Likun
    Liu, Juan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [28] Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy
    Jiao, Zhongyu
    Zhang, Jun
    CARCINOGENESIS, 2023, 44 (12) : 795 - 808
  • [29] Blocking of the PD-1/PD-L1 interaction by an affinity peptide for cancer immunotherapy
    Luo, H.
    Li, X.
    Zhu, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1782 - 1782
  • [30] PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
    Jiang, Yongshuai
    Chen, Ming
    Nie, Hong
    Yuan, Yuanyang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1111 - 1122
12345